Jecho Biopharmaceuticals Co., Ltd.

This early-phase study is testing a new biologic drug called JLM019 in adults with advanced solid tumors or lymphomas that have come back or not responded to treatment. The drug is given as a weekly intravenous infusion, and the main goals are to check its safety, find the right …

This study tests a new drug called JL15003, given as an injection directly into the brain tumor or the space left after surgery. It is for adults with recurrent glioblastoma, an aggressive brain cancer that has come back after standard treatment. The trial aims to see if the drug…